← back to search

Helene Alexanderson

Public Health Agency of Sweden ·
Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Inflammatory Myopathies and Dermatomyositis, Muscle Physiology and Disorders, Parkinson's Disease and Spinal Disorders, and Rheumatoid Arthritis Research and Therapies.
h-index
42
citations
4,817
works
136
NIH funding
primary concept
email

Recent publications

The EULAR points to consider regarding the development of criteria for the assessment of the disease activity in adult-onset Still’s disease
EULAR Rheumatology Open 2025cited by 1position: middledoi
POS1123 Myositis Community Proposes a Framework to Guide Clinical Trials and Ensure Patient Safety during Influx of CAR-Based Therapies
Annals of the Rheumatic Diseases 2025cited by 0position: middledoi
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Annals of the Rheumatic Diseases 2023cited by 113position: middledoi
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group
Seminars in Arthritis and Rheumatism 2022cited by 33position: lastdoi
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease
Frontiers in Pharmacology 2022cited by 24position: middledoi
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc
Best Practice & Research Clinical Rheumatology 2021cited by 43position: middledoi
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)
Best Practice & Research Clinical Rheumatology 2021cited by 34position: middledoi
Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Patients With Dermatomyositis and Polymyositis
The Journal of Rheumatology 2020cited by 43position: lastdoi
Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies
Annals of the Rheumatic Diseases 2019cited by 90position: middledoi
Idiopathic Inflammatory Myopathies
Rheumatic Disease Clinics of North America 2019cited by 74position: middledoi
Exercise in Myositis
Current Treatment Options in Rheumatology 2018cited by 45position: firstdoi
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Annals of the Rheumatic Diseases 2017cited by 138position: middledoi
Endurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis
Arthritis & Rheumatology 2016cited by 93position: middledoi
Physical exercise as a treatment for adult and juvenile myositis
Journal of Internal Medicine 2016cited by 56position: firstdoi
Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents
Arthritis Research & Therapy 2016cited by 29position: middledoi
Resistive Home Exercise in Patients with Recent-onset Polymyositis and Dermatomyositis — A Randomized Controlled Single-blinded Study with a 2-year Followup
The Journal of Rheumatology 2014cited by 91position: firstdoi
Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis
Arthritis Research & Therapy 2013cited by 118position: lastdoi
Improvement in Health and Possible Reduction in Disease Activity Using Endurance Exercise in Patients With Established Polymyositis and Dermatomyositis: A Multicenter Randomized Controlled Trial With a 1‐Year Open Extension Followup
Arthritis Care & Research 2013cited by 102position: lastdoi
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
Annals of the Rheumatic Diseases 2013cited by 101position: middledoi
TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis
Annals of the Rheumatic Diseases 2012cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ingrid E. Lundberg · Karolinska University Hospital10 papers (2012–2022)Maryam Dastmalchi · Karolinska University Hospital7 papers (2013–2017)Ingela Loell · Karolinska University Hospital4 papers (2013–2016)Li Alemo Munters · Karolinska University Hospital4 papers (2013–2016)Mona Esbjörnsson · Karolinska University Hospital3 papers (2013–2016)Malin Regardt · Karolinska University Hospital3 papers (2013–2022) · 2 papers (2021–2023) · 2 papers (2013–2013)Maria Lidén · Science for Life Laboratory2 papers (2013–2013)Håkan Westerblad · Lithuanian Sports University2 papers (2012–2013)Jiří Vencovský · Shanxi Medical University2 papers (2017–2019)Janet L. Poole · University of New Mexico2 papers (2021–2023) · 2 papers (2023–2025)Joan Raouf · Karolinska University Hospital2 papers (2016–2016)Marina Korotkova · Karolinska University Hospital2 papers (2016–2016)Johan Rönnelid · Science for Life Laboratory2 papers (2017–2019) · 2 papers (2023–2025)Eva Lindroos · Karolinska Institutet2 papers (2016–2017)Mei Zong · Karolinska University Hospital2 papers (2012–2013)Inger Nennesmo · Karolinska University Hospital2 papers (2013–2016)